From July 1, 2022 to September 30, 2022, the company has repurchased 76,775 shares, representing 0.06% for CNY 7.12 million. With this, the company has completed the repurchase of 901,775 shares, representing 0.67% for CNY 123.1 million under the buyback announced on October 29, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.06 CNY | +1.22% | -1.40% | -32.86% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.86% | 938M | |
+3.96% | 93.97B | |
+6.58% | 41.61B | |
-13.20% | 33.32B | |
+77.12% | 28.8B | |
-16.02% | 15.61B | |
-8.17% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 29, 2021.